Mon, 21 Sept 2026
03:55:20 pm
Rudransh Sangwan
Published at: September 21, 2026, 11:39 AM
Synopsis
Moneyview IPO 2026 opens on September 24 with a ₹750 crore fresh issue and ₹341.68 crore OFS. Check price band, lot size, financials and key details.

The Moneyview IPO is scheduled to open for subscription on September 24, 2026, and close on September 28, 2026. The mainboard IPO includes a fresh issue of ₹750 crore and an offer for sale (OFS) worth approximately ₹341.68 crore.
The Moneyview IPO price band is fixed at ₹32 to ₹34 per share, with a lot size of 441 shares. Retail investors need ₹14,994 for one lot at the upper price band. The tentative listing date is October 1, 2026, on the NSE and BSE.
The latest reported Moneyview IPO GMP is ₹0 as of September 21, 2026. At the upper issue price of ₹34, the estimated listing price based on GMP is ₹34, indicating a 0% premium.
Grey market premium (GMP) is unofficial and can change before listing. It does not guarantee the actual listing price.
| IPO Metric | Details |
|---|---|
| IPO GMP Today | ₹0 |
| Price Band | ₹32–₹34 |
| Estimated Listing Price | ₹34 |
| Estimated Premium | 0% |
| Issue Size | ₹1,091.68 crore |
| IPO Opens | September 24, 2026 |
| IPO Closes | September 28, 2026 |
| Expected Listing | October 1, 2026 |
| IPO Detail | Information |
|---|---|
| Issue Type | Mainboard, Bookbuilding |
| Fresh Issue | ₹750 crore |
| Offer for Sale | ₹341.68 crore |
| Lot Size | 441 shares |
| Minimum Investment | ₹14,994 |
| Face Value | ₹1 |
| Listing | NSE and BSE |
| Registrar | MUFG Intime India |
| Lead Managers | Axis Capital, BOFA Securities, IIFL Capital and Kotak Mahindra Capital |
| Event | Date |
|---|---|
| IPO Opens | September 24, 2026 |
| IPO Closes | September 28, 2026 |
| Allotment | September 29, 2026 |
| Refund | September 30, 2026 |
| Share Credit | September 30, 2026 |
| Listing | October 1, 2026 |
| Investor Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 441 | ₹14,994 |
| Retail Maximum | 13 | 5,733 | ₹1,94,922 |
| S-HNI Minimum | 14 | 6,174 | ₹2,09,916 |
| S-HNI Maximum | 66 | 29,106 | ₹9,89,604 |
| B-HNI Minimum | 67 | 29,547 | ₹10,04,598 |
Amounts are calculated using the upper price band of ₹34 per share.
Moneyview reported growth in total income and EBITDA between FY25 and FY26. Profit after tax increased from ₹240.28 crore to ₹242.71 crore.
| Financial Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Total Income | ₹1,389.24 Cr | ₹2,378.53 Cr | ₹3,404.27 Cr |
| Profit After Tax | ₹171.15 Cr | ₹240.28 Cr | ₹242.71 Cr |
| EBITDA | ₹328.70 Cr | ₹697.98 Cr | ₹968.92 Cr |
| Net Worth | ₹1,606.64 Cr | ₹1,918.66 Cr | ₹2,225.42 Cr |
| Total Borrowings | ₹1,708.92 Cr | ₹3,413.37 Cr | ₹5,157.04 Cr |
| Assets | ₹3,519.50 Cr | ₹5,632.42 Cr | ₹8,104.85 Cr |
For the three months ended June 30, 2026, the company reported total income of ₹1,065.09 crore and profit after tax of ₹173.80 crore.
At the upper price band, the estimated post-issue market capitalisation is ₹5,984.79 crore.
| Valuation Metric | Value |
|---|---|
| Pre-IPO Market Capitalisation | ₹5,234.79 Cr |
| Post-IPO Market Capitalisation | ₹5,984.79 Cr |
| Pre-IPO EPS | ₹1.58 |
| Post-IPO EPS | ₹3.95 |
| Pre-IPO P/E | 21.52x |
| Post-IPO P/E | 8.61x |
Investors should assess valuation alongside profitability, borrowings, lending exposure and the company's growth plans.
Moneyview operates in the fintech and financial services sector, connecting customers with banks, NBFCs, insurers and other financial institutions.
Key strengths:
Key risks:
The reported GMP of ₹0 indicates no unofficial premium over the upper issue price. Investors should consider the company's financial performance, risks and official IPO documents rather than relying only on GMP.
The latest reported Moneyview IPO GMP is ₹0 as of September 21, 2026. GMP is unofficial and may change.
The price band is ₹32 to ₹34 per share.
The minimum lot size is 441 shares.
The minimum retail investment is ₹14,994 at the upper price band.
The IPO is scheduled to open on September 24, 2026.
The tentative listing date is October 1, 2026, on the NSE and BSE.
Investors can check allotment status through the MUFG Intime India registrar website after allotment is finalized.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO details and GMP figures may change. GMP is unofficial and does not guarantee listing gains. Investors should review the final offer documents and conduct their own research.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Moneyview IPO 2026 opens on September 24 with a ₹750 crore fresh issue and ₹341.68 crore OFS. Check price band, lot size, financials and key details.

Vardaan Biotech has filed its DRHP for an IPO featuring a fresh issue of up to 3.50 crore shares. Explore its seed business and listing plans.

Cotton yarn maker Rudra Cottex filed its DRHP on September 17. Here’s a look at its proposed IPO size, financial performance and listing plans.

ArMee Infotech IPO details include the price band, issue size, subscription dates, minimum investment, IPO proceeds, business profile and financial...

Sonaselection India IPO subscription status shows category-wise bidding from retail investors, NIIs and QIBs.